In this section you may find relevant information regarding the safety, efficacy and toxicology of the drugs actually used for Rare Diseases as well as:
Good Laboratory Practices (GLPs),
Animal models: juvenile, humanised animal models, disease specific animal models and documents that may support you to correctly use animal models from ethical points of view.
Proof of principle
In silico modelling